Latest News
Effective December 26, 2014, the Office of Environmental Health Hazard Assessment (OEHHA) is adding dibenzanthracenes (as a chemical group), dibenz[a,c]anthracene, and dibenz[a,j]anthracene to the list of chemicals known to the state to cause cancer.
RFCI requests OEHHA to determine that exposures to DINP in vinyl flooring products do not present significant cancer risks under Proposition 65, and do not require a warning.
Notice of a public hearing on February 25, 2015 from 10:00 a.m. to 1:00 p.m. for comment on a request for a Safe Use Determination for Diisononyl Phthalate (DINP) in vinyl flooring products.
Notice of a 2015 public hearing for comment on a request for a Safe Use Determination for Diisononyl Phthalate (DINP) in vinyl flooring products.
Public comment period (through March 11, 2015) on the proposal to adopt a Proposition 651 No Significant Risk Level (NSRL) of 146 micrograms per day for diisononyl phthalate (DINP), by amending Title 27, California Code of Regulations, section 25705(b)
In October 2013, to better understand workplace exposures, OEHHA developed a physiologically-based pharmacokinetic (PBPK) model describing the relationship between airborne lead and blood levels in workers and released to the public. An Errata sheet with a correction to Table A-2 was added to this document.
At the request of the California Department of Public Health (CDPH), the Office of Environmental Health Hazard Assessment (OEHHA) has developed a PBPK (physiologically-based pharmacokinetic) model describing the relationship between airborne lead and blood lead levels in workers.
On November 19, 2014, the Office of Administrative Law approved an amendment to Title 27, California Code of Regulations, section 25903, Appendix A.
Outcome and meeting summary of the public meeting on the consideration of chemicals as known to the state to cause cancer: Dibenzanthracenes and N-nitrosomethyl-n-alkylamines.
OEHHA released drafts of its proposed Reference Exposure Levels for toluene diisocyanate and methylene diphenyl diisocyanate for review by the Scientific Review Panel prior to its meeting.